WebApr 13, 2024 · GlaxoSmithKline (GSK) is acquiring San Mateo, Calif.-based Sierra Oncology in a $1.9B cash deal to bolster its cancer drug portfolio.Under the agreement, outstanding shares of Sierra... WebApr 13, 2024 · Britain's GlaxoSmithKline sought to bolster its cancer business on Wednesday by agreeing a $1.9 billion deal to buy U.S. drug developer Sierra Oncology, the latest move to fend off pressure from activist shareholder Elliott. GSK has been facing mounting calls to shore up its drug pipeline since Elliott built up a significant stake in the …
Oncology GSK
WebApr 13, 2024 · GlaxoSmithKline plc (LSE/NYSE: GSK) and Sierra Oncology, Inc (Nasdaq: SRRA) today announced that the companies have entered into an agreement under … WebWhat started as an effort to find a strategic partner turned into a $1.9 billion buyout from GlaxoSmithKline, which didn’t just want an arm's-length deal. Chief Commercial Officer … smileys microsoft
GlaxoSmithKline completes acquisition of Sierra Oncology
WebApr 13, 2024 · April 13 (Reuters) - Britain's GlaxoSmithKline (GSK.L) sought to bolster its cancer business on Wednesday by agreeing a $1.9 billion deal to buy U.S. drug … WebApr 13, 2024 · Sierra Oncology Sierra Oncology is a clinical-stage drug development company that advances targeted therapeutics for the treatment of cancer patients. Acquiring Organization: GlaxoSmithKline GlaxoSmithKline develops and markets products in the areas of pain relief, respiratory, digestive health, oral health, nutrition and skin. WebApr 13, 2024 · GlaxoSmithKline plc (LSE/NYSE: GSK) and Sierra Oncology, Inc (Nasdaq: SRRA) today announced that the companies have entered into an agreement under which GSK will acquire Sierra Oncology, a California-based, late-stage biopharmaceutical company focused on targeted therapies for the treatment of rare forms of cancer, for $55 … smileys midlothian